News

2025 Debra: The Butterfly Skin Charity

Published on: 04/03/2025

2025 Debra: The Butterfly Skin Charity

DEBRA UK wants to fund you to help create a world where no one suffers with epidermolysis bullosa (EB). This painful and life-limiting condition affects many major organs of the body, including skin, eyes, kidneys, gastrointestinal and urinary tracts, causing painful blistering, scarring and increased risk of skin cancer. We fund research on all of the four genetic types of EB and encourage applications from researchers working on EBS where there is an unmet need.

Funding news

2025 grant call: 1 February – 31 March 2025

How to apply?

See below full information on our research strategy, funding criteria and application deadlines. To apply for our funding, please download our application form, complete and submit by email to research@debra.org.uk.

You can also sign up to our researchers database to be kept informed of future research funding and other opportunities.

If you wish to discuss your proposed research area in advance of submission, please contact Dr Sagair Hussain, Director of Research: Sagair.Hussain@debra.org.uk.

Download our application form

 

Summary of research strategy and application process

DEBRA UK wants to fund you to help create a world where no one suffers with epidermolysis bullosa (EB). This painful and life-limiting condition affects many major organs of the body, including skin, eyes, kidneys, gastrointestinal and urinary tracts, causing painful blistering, scarring and increased risk of skin cancer. We fund research on all of the four genetic types of EB and encourage applications from researchers working on EBS where there is an unmet need.

Download our research strategy

Our research funding is awarded through a rigorous process including experts by experience and scientific experts and is supported through our membership of the AMRC.

Applicants may also choose to attend our Applications Clinic to involve people living with EB in the design of their application.

DEBRA UK funding criteria

Our key criteria will be:

  • scientific and treatment potential in relation to EB.
  • applications must have clear aims and objectives to advance scientific understanding of EB and therapeutic interventions.
  • projects must be feasible and achievable in the stated time period, as funding cannot be extended.
  • applications will not be accepted by DEBRA UK from principal investigators who were awarded our project grant funding in the previous year as a PI.
  • only one application per DEBRA UK grant type will be considered from each principal investigator.

We also co-fund research with other charity partners.

NEWS​

Related News

Health Technology Procurements: Advancing Catalonia’s Digital Health Strategy

29 Apr 2025
CatSalut has published through CTTI two procurement opportunities for technology partners to support Catalonia's ambitious Digital Health Strategy 202...

Cancer Grand Challenges

29 Apr 2025
Cancer Grand Challenges is a global research initiative that identifies the toughest challenges in cancer research. With awards of up to $25m, it empo...

Global Incubator Programme: USA (Houston) Healthtech – Medical Devices

29 Apr 2025
Delivered in partnership with the Texas Medical Center Innovation (TMCi), Houston, USA and supported by the Department for Business & Trade (DBT),...

Global Business Innovation Programme: Digital Health, USA

29 Apr 2025
Innovate UK seeks up to 15 ambitious UK small businesses (with under 250 employees) who want to explore digital health opportunities in the USA.

Global Incubator Programme: Canada – AI for Health

29 Apr 2025
Delivered by Innovate UK, in partnership with MaRS, this Global Incubator Programme (GIP) provides an opportunity for UK-based companies to expand int...

Accelerated Knowledge Transfer

29 Apr 2025
Innovate UK Accelerated Knowledge Transfer (AKT) is jointly delivered by Innovate UK and Innovate UK Business Connect.

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *